Iba – Transparency Notification
31 August 2023 - 6:00PM
Iba – Transparency Notification
(Article 14, paragraph 1 of the law of 2
May 2007 on the disclosure of major holdings)
Louvain-la-Neuve, Belgium, August 31
2023 18:00
Summary of the notification
IBA (Ion Beam Applications), the world’s leading
provider of proton therapy solutions for the treatment of cancer,
announces that it has to issue a transparency notification, in
accordance with Article 14, al. 1 of the Transparency Law of May 2,
2007 on disclosure of major holdings, further to the notification
received on August 29th 2023.
In its notification, NS Partners Europe S.A has
notified, that following the passive crossing of a threshold, its
total holding in IB SA has crossed upwards the 1% threshold.
Content of the notification
- Reason for the notification: Acquisition or disposal of
voting securities or voting rights Notification by: A parent
undertaking or a controlling person
- Persons subject to the notification
requirement: NS Partners Europe S.A.11 Boulevard de
la Foire, L-1528 Luxembourg, Luxembourg.
- Date on which the threshold is crossed: 13/07/2023
- Threshold crossed (in %) : 1%
- Denominator : 40.159.157
- Notified details: (extract of the received notification
form)
- Full chain of controlled undertakings through which the
holding is effectively held
1. There is no natural person who directly or
indirectly hold a sufficient percentage of the voting rights or a
sufficient shareholding in thecapital of the company.2. There is no
natural person who control the company by other means (e.g. right
to appoint or revoke main directors, veto rights, etc.).As a
result, the ultimate controlling persons are the board members: Mr.
Paolo FARAONE, Mr. Christophe LENTSCHAT, and Mr. GrégoireNOTZ.
NS Partners Europe S.A. acts as AIFM of the fund
Lux-Investment Professionals SICAV-FIS S.A. Ultimately holding IBA
shares.NS Partners Europe S.A., in agreement with Lux-Investment
Professionals Sicav-FIS S.A. prospectus and the AIFM Voting right
policy may exercise the voting rights on a discretionary basis,
without specificinstructions from the unit holder of the fund.
About IBAIBA (Ion Beam
Applications S.A.) is the world leader in particle accelerator
technology. The company is the leading supplier of equipment and
services in the field of proton therapy, considered to be the most
advanced form of radiation therapy available today. IBA is also a
leading player in the fields of industrial sterilization,
radiopharmaceuticals and dosimetry. The company, based in
Louvain-la-Neuve, Belgium, employs approximately 1,800 people
worldwide. IBA is a certified B Corporation (B Corp) meeting the
highest standards of verified social and environmental
performance.
IBA is listed on the pan-European stock exchange
EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).More
information can be found at: www.iba-worldwide.com
For further information, please
contact:
Valérie Van
ImpeParalegal
+32479267809legal@iba-group.com
- 29082023-IBA-LIP Transparencynotification EN
Ion Beam Applications (EU:IBAB)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Ion Beam Applications (EU:IBAB)
Historical Stock Chart
Von Mai 2023 bis Mai 2024